1-(5-Chloro-1-ethyl-6-oxo-1,6-dihydropyridazin-4-yl)pyrrolidine-3-carboxylic acid

Catalog No. :
ACPGAI145
CAS No. :
1708288-16-7
Molecular Formula :
C11H14ClN3O3
Molecular Weight :
271.70

IUPAC Name:1-(5-chloro-1-ethyl-6-oxo-1,6-dihydropyridazin-4-yl)pyrrolidine-3-carboxylic acid

1-(5-Chloro-1-ethyl-6-oxo-1,6-dihydropyridazin-4-yl)pyrrolidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$269.00Login to see priceIn stockInquiry
250mg97%$447.00Login to see priceIn stockInquiry
1g97%$1244.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Chloro-1-ethyl-6-oxo-1,6-dihydropyridazin-4-yl)pyrrolidine-3-carboxylic acid
IUPAC Name1-(5-chloro-1-ethyl-6-oxo-1,6-dihydropyridazin-4-yl)pyrrolidine-3-carboxylic acid
MDL No.MFCD26382133
Molecular FormulaC11H14ClN3O3
Molecular Weight271.70
SMILESO=C(C1CN(C(C=NN2CC)=C(Cl)C2=O)CC1)O
InChI KeyWWZIFGGNYPJGKB-UHFFFAOYSA-N
Synonym1-(5-Chloro-1-ethyl-6-oxo-1,6-dihydro-pyridazin-4-yl)-pyrrolidine-3-carboxylic acid;3-Pyrrolidinecarboxylic acid, 1-(5-chloro-1-ethyl-1,6-dihydro-6-oxo-4-pyridazinyl)-
CAS No.1708288-16-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPGAI145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPGAI145 route product structure diagram
    ACPGAI1451708288-16-7 In Stock
Inquiry

2. ACPGAI145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPGAI145 route product structure diagram
    ACPGAI1451708288-16-7 In Stock
Inquiry

Comments (0)